Efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score to predict gestational trophoblastic tumor from hydatidiform mole

Efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score to predict gestational trophoblastic tumor from hydatidiform mole

A prospective longitudinal analytic study assessing the efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score in predicting malignancy after hydatidiform mole had been performed. Of the parameter evaluated; age of patients, type of hydatidiform mole, uterine enlargement...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical journal of Indonesia 2004-01, Vol.13 (1), p.40
Hauptverfasser: Khrismawan, Khrismawan, Saleh, Agustria Z., Sanif, Rizal, Theodorus, Theodorus
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 40
container_title Medical journal of Indonesia
container_volume 13
creator Khrismawan, Khrismawan
Saleh, Agustria Z.
Sanif, Rizal
Theodorus, Theodorus
description A prospective longitudinal analytic study assessing the efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score in predicting malignancy after hydatidiform mole had been performed. Of the parameter evaluated; age of patients, type of hydatidiform mole, uterine enlargement, serum hCG level, lutein cyst, and presence of complicating factors were significant risk factors for malignancy after hydatidiform mole were evacuated (p
doi_str_mv 10.13181/mji.v13i1.128
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1625398608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3498352181</sourcerecordid><originalsourceid>FETCH-LOGICAL-c137t-757c5906784ea2832485d5acfdbe56ca5d28b7eed9a2b179fbd85dd57957644f3</originalsourceid><addsrcrecordid>eNpVkL1OwzAYRS0EElXpymyJBYaE2I5jZ0Rt-JGqspQ5cvzTukriYrtAH4T3xSosTN9wj67udwC4RkWOCOLoftjZ_AMRi3KE-RmYYExxxgtOzsGk4JRkiDFyCWYh2K5AhBcVxXgCvhtjrBTyCJ2Bq2a9mMPblf6Ezbjpxajg2rv91nW9CNFKuLBBi6DhXI9R-zu4924zulNkR6W_YJDOaxhdSrSyMsKNDlFE60bRw_ivKx4G56HxboDbo0qMssb5AQ6u11fgwog-6NnfnYK3x2Y9f86Wr08v84dlJhFhMWOUSVoXFeOlFpgTXHKqqJBGdZpWUlCFece0VrXAHWK16VQCFGU1ZVVZGjIFN7-96ZH3Q5ra7tzBp62hRRWmpOZVMjgF-S8lvQvBa9PuvR2EP7aoaE_222S_Pdlvk33yA0MCe8I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1625398608</pqid></control><display><type>article</type><title>Efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score to predict gestational trophoblastic tumor from hydatidiform mole</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Khrismawan, Khrismawan ; Saleh, Agustria Z. ; Sanif, Rizal ; Theodorus, Theodorus</creator><creatorcontrib>Khrismawan, Khrismawan ; Saleh, Agustria Z. ; Sanif, Rizal ; Theodorus, Theodorus</creatorcontrib><description>A prospective longitudinal analytic study assessing the efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score in predicting malignancy after hydatidiform mole had been performed. Of the parameter evaluated; age of patients, type of hydatidiform mole, uterine enlargement, serum hCG level, lutein cyst, and presence of complicating factors were significant risk factors for malignancy after hydatidiform mole were evacuated (p&lt;0.032). The study were done on 50 women diagnosed with hydatidiform mole with 1 year observation (January 2001-December 2002) at the Department of Obstetrics and Gynecology, Mohammad Hoesin Hospital, Palembang. The results showed that the NETDC prognostic index score predicted malignancy in 50% of high risk group and 10% in low risk group (p&lt;0.05). This showed a higher number than that found by the WHO (19%-30%). The risk for incidence of malignancy after hydatidiform mole in the high risk group is 9.0 times higher compared to that of the low risk group (CI: 1.769-45.786). (Med J Indones 2004; 13: 40-6)</description><identifier>ISSN: 0853-1773</identifier><identifier>EISSN: 2252-8083</identifier><identifier>DOI: 10.13181/mji.v13i1.128</identifier><language>eng</language><publisher>Jakarta: Faculty of Medicine Universitas Indonesia</publisher><ispartof>Medical journal of Indonesia, 2004-01, Vol.13 (1), p.40</ispartof><rights>Copyright Faculty of Medicine Universitas Indonesia Jan/Mar 2004</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Khrismawan, Khrismawan</creatorcontrib><creatorcontrib>Saleh, Agustria Z.</creatorcontrib><creatorcontrib>Sanif, Rizal</creatorcontrib><creatorcontrib>Theodorus, Theodorus</creatorcontrib><title>Efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score to predict gestational trophoblastic tumor from hydatidiform mole</title><title>Medical journal of Indonesia</title><description>A prospective longitudinal analytic study assessing the efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score in predicting malignancy after hydatidiform mole had been performed. Of the parameter evaluated; age of patients, type of hydatidiform mole, uterine enlargement, serum hCG level, lutein cyst, and presence of complicating factors were significant risk factors for malignancy after hydatidiform mole were evacuated (p&lt;0.032). The study were done on 50 women diagnosed with hydatidiform mole with 1 year observation (January 2001-December 2002) at the Department of Obstetrics and Gynecology, Mohammad Hoesin Hospital, Palembang. The results showed that the NETDC prognostic index score predicted malignancy in 50% of high risk group and 10% in low risk group (p&lt;0.05). This showed a higher number than that found by the WHO (19%-30%). The risk for incidence of malignancy after hydatidiform mole in the high risk group is 9.0 times higher compared to that of the low risk group (CI: 1.769-45.786). (Med J Indones 2004; 13: 40-6)</description><issn>0853-1773</issn><issn>2252-8083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVkL1OwzAYRS0EElXpymyJBYaE2I5jZ0Rt-JGqspQ5cvzTukriYrtAH4T3xSosTN9wj67udwC4RkWOCOLoftjZ_AMRi3KE-RmYYExxxgtOzsGk4JRkiDFyCWYh2K5AhBcVxXgCvhtjrBTyCJ2Bq2a9mMPblf6Ezbjpxajg2rv91nW9CNFKuLBBi6DhXI9R-zu4924zulNkR6W_YJDOaxhdSrSyMsKNDlFE60bRw_ivKx4G56HxboDbo0qMssb5AQ6u11fgwog-6NnfnYK3x2Y9f86Wr08v84dlJhFhMWOUSVoXFeOlFpgTXHKqqJBGdZpWUlCFece0VrXAHWK16VQCFGU1ZVVZGjIFN7-96ZH3Q5ra7tzBp62hRRWmpOZVMjgF-S8lvQvBa9PuvR2EP7aoaE_222S_Pdlvk33yA0MCe8I</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Khrismawan, Khrismawan</creator><creator>Saleh, Agustria Z.</creator><creator>Sanif, Rizal</creator><creator>Theodorus, Theodorus</creator><general>Faculty of Medicine Universitas Indonesia</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BVBZV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20040101</creationdate><title>Efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score to predict gestational trophoblastic tumor from hydatidiform mole</title><author>Khrismawan, Khrismawan ; Saleh, Agustria Z. ; Sanif, Rizal ; Theodorus, Theodorus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c137t-757c5906784ea2832485d5acfdbe56ca5d28b7eed9a2b179fbd85dd57957644f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Khrismawan, Khrismawan</creatorcontrib><creatorcontrib>Saleh, Agustria Z.</creatorcontrib><creatorcontrib>Sanif, Rizal</creatorcontrib><creatorcontrib>Theodorus, Theodorus</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>East &amp; South Asia Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Medical journal of Indonesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khrismawan, Khrismawan</au><au>Saleh, Agustria Z.</au><au>Sanif, Rizal</au><au>Theodorus, Theodorus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score to predict gestational trophoblastic tumor from hydatidiform mole</atitle><jtitle>Medical journal of Indonesia</jtitle><date>2004-01-01</date><risdate>2004</risdate><volume>13</volume><issue>1</issue><spage>40</spage><pages>40-</pages><issn>0853-1773</issn><eissn>2252-8083</eissn><abstract>A prospective longitudinal analytic study assessing the efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score in predicting malignancy after hydatidiform mole had been performed. Of the parameter evaluated; age of patients, type of hydatidiform mole, uterine enlargement, serum hCG level, lutein cyst, and presence of complicating factors were significant risk factors for malignancy after hydatidiform mole were evacuated (p&lt;0.032). The study were done on 50 women diagnosed with hydatidiform mole with 1 year observation (January 2001-December 2002) at the Department of Obstetrics and Gynecology, Mohammad Hoesin Hospital, Palembang. The results showed that the NETDC prognostic index score predicted malignancy in 50% of high risk group and 10% in low risk group (p&lt;0.05). This showed a higher number than that found by the WHO (19%-30%). The risk for incidence of malignancy after hydatidiform mole in the high risk group is 9.0 times higher compared to that of the low risk group (CI: 1.769-45.786). (Med J Indones 2004; 13: 40-6)</abstract><cop>Jakarta</cop><pub>Faculty of Medicine Universitas Indonesia</pub><doi>10.13181/mji.v13i1.128</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0853-1773
ispartof Medical journal of Indonesia, 2004-01, Vol.13 (1), p.40
issn 0853-1773
2252-8083
language eng
recordid cdi_proquest_journals_1625398608
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title Efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score to predict gestational trophoblastic tumor from hydatidiform mole
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A02%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20NETDC%20(New%20England%20Trophoblastic%20Disease%20Center)%20prognostic%20index%20score%20to%20predict%20gestational%20trophoblastic%20tumor%20from%20hydatidiform%20mole&rft.jtitle=Medical%20journal%20of%20Indonesia&rft.au=Khrismawan,%20Khrismawan&rft.date=2004-01-01&rft.volume=13&rft.issue=1&rft.spage=40&rft.pages=40-&rft.issn=0853-1773&rft.eissn=2252-8083&rft_id=info:doi/10.13181/mji.v13i1.128&rft_dat=%3Cproquest_cross%3E3498352181%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1625398608&rft_id=info:pmid/&rfr_iscdi=true